logo

For the Inventor, By the Inventor

Osaka, Japan

Sumitomo Pharma Co., Ltd.


USPTO Granted Patents = 65



Trademarks = 42

Forward Citations = 13

Loading Chart...
Loading Chart...

143 inventors (with patents filed for the assignee):

goldMedal Hitoshi Ban (17 out of 37 patents)

silverMedal Seiji Kamioka (7 out of 14 patents)

bronzeMedal Masayo Takahashi (6 out of 16 patents)

4.  Yoshiaki Isobe (6 out of 28 patents)

5.  Hitoshi Watanabe (6 out of 11 patents)

6.  Yohei Ikuma (5 out of 12 patents)

7.  Naoaki Shimada (4 out of 26 patents)

8.  Wataru Hirose (4 out of 10 patents)

9.  Suguru Yamasaki (4 out of 7 patents)

10.  Yoshiki Sasai (4 out of 35 patents)

11.  Hidefumi Yoshinaga (4 out of 18 patents)

12.  Hidenori Kimura (4 out of 11 patents)

13.  Jeremy Besnard (4 out of 9 patents)

14.  Yosuke Takanashi (4 out of 10 patents)

15.  Takao Kuroda (4 out of 30 patents)


Core Competencies:
Vaccine Adjuvants
Retinal Tissue Production
Antibody-Drug Conjugates
Heterocyclic Derivatives
Dopaminergic Neuron Progenitors
Biosignal Measuring Devices
Psychiatric Condition Management
Alzheimer's Disease Diagnostics
Influenza Vaccine Composition
Cellular Medicine Transfer
Serotonin Receptor Activity
Therapeutic Drugs for Parkinson's

65 patents:

1. 12503463 - Aliphatic acid amide derivative (2025-12-23),
2. 12440560 - Substituted pyrimidines as vaccine adjuvants (2025-10-14),
3. 12427192 - Water soluble adjuvant and composition containing same (2025-09-30),
4. 12410154 - 5-heteroaryl-1H-pyrazol-3-amine derivative (2025-09-09),
5. 12404268 - 2-heteroaryl aminoquinazolinone derivative (2025-09-02),
6. 12398149 - Dihydrochromene derivatives (2025-08-26),
7. 12398125 - Nitrogen-containing saturated heterocyclyl derivative (2025-08-26),
8. 12385008 - Method for producing retinal tissue (2025-08-12),
9. 12383608 - WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides (2025-08-12),
10. 12312419 - Hemiasterlin derivative having cysteine residue (2025-05-27),
11. 12304889 - Method for producing cis-(-)-flocino piperidol (2025-05-20),
12. 12291720 - Production method for retinal tissue (2025-05-06),
13. 12285543 - Human cell population comprising human retinal progenitor cells without an ISL1 gene for transplantation and methods of use thereof (2025-04-29),
14. 12263167 - Optically active azabicyclo ring derivative (2025-04-01),
15. 12226480 - Combination drug including TLR7 agonist (2025-02-18),
Sumitomo Pharma Co., Ltd. is a pharmaceutical company based in Japan. With a focus on research and development, Sumitomo Pharma is committed to improving the health and well-being of people globally. They strive to create innovative and high-quality pharmaceutical products that meet the needs of patients and healthcare professionals. For more information about Sumitomo Pharma Co., Ltd., please visit their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

65 Patents

#135 in Osaka

#1,444 in Japan

#11,030 in the World

...
Osaka, Japan

Sumitomo Pharma Co., Ltd.

Forward Citations = 13

143 inventors:

goldMedal Hitoshi Ban (17 out of 37 patents)

silverMedal Seiji Kamioka (7 out of 14 patents)

bronzeMedal Masayo Takahashi (6 out of 16 patents)

4.  Yoshiaki Isobe (6 out of 28 patents)

5.  Hitoshi Watanabe (6 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…